Digestive Disease Week (DDW) 2024
Washington, DC, US 18 May 2024 - 21 May 2024
Physical activity substantially cuts cirrhosis risk in MASLD patients
A study presented at DDW 2024 showed that adequate physical activity reduces the risk of cirrhosis in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).
Physical activity substantially cuts cirrhosis risk in MASLD patients
19 Jun 2024
Blood-based CRC screening platform delivers promising performance
An investigational blood-based test performs satisfactorily for the early detection of colorectal cancer (CRC), having met all prespecified primary endpoints in the large PREEMPT CRC trial.
Blood-based CRC screening platform delivers promising performance
13 Jun 2024
Statins may protect against primary sclerosing cholangitis in IBD patients
Patients with inflammatory bowel disease (IBD) who use statins appear to have a substantially reduced risk of primary sclerosing cholangitis (PSC), as shown in a retrospective study.
Statins may protect against primary sclerosing cholangitis in IBD patients
12 Jun 2024
Green kiwi may improve GI symptoms in IBS-C patients
Habitual intake of green kiwifruit may effectively relieve abdominal pain and constipation in adults with constipation-predominant irritable bowel syndrome (IBS-C), findings from a study presented at DDW 2024 suggest.
Green kiwi may improve GI symptoms in IBS-C patients
10 Jun 2024
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
Patients with postacute COVID-19 syndrome (PACS) may benefit from faecal microbiota transplantation (FMT) treatment, which helps reduce anxiety and improve sleep quality, suggests a study.
